Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
RNA | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3020 CALLAN ROAD, 92121 SAN DIEGO
- Sector:
- Manufacturing
Description
Avidity Biosciences, Inc. is a biopharmaceutical company developing a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs). The company's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide-based therapies. This approach is designed to overcome challenges in drug delivery by enabling targeted transport of RNA therapeutics to specific cells and tissues, such as muscle, that were previously inaccessible. Avidity's pipeline is initially focused on developing treatments for rare muscle diseases, with the objective of addressing the underlying genetic drivers of these conditions and expanding into other therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Avidity Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Avidity Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Avidity Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
